Incyte (INCY) Tops Q2 EPS by 45c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Incyte (INCY) Sell-Off on Opzelura Miss an 'Overreaction' - Truist
August 2, 2022 12:45 PM EDTTruist Securities analyst Srikripa Devarakonda reiterated a Buy rating and $95.00 price target on Incyte (NASDAQ: INCY), saying the stock pullback from the Opzelura miss is an overreaction.
The analyst commented, "While JAKAFI beat cons ($598M vs. $587M), stock weak on... More
